Medical News

RSS

Researchers study the possible use of carboranes

When protein plaque builds up in the blood, it can result in serious diseases such as heart disease and Alzheimer's.

25 Apr 2007

Overconsumption syndrome exists with alcohol to!

While many people are aware of the potential health hazards posed by oversized food servings, a Purdue University expert says consumers face the same risks at the neighborhood bar as they do at a buffet bar.

25 Apr 2007

Evaluation of primary urinary tract infection in infants

They reviewed the clinical and laboratory findings as well as the diagnosis and treatment. This study is important since urinary tract infection is one of the most common causes of unexplained fevers in infants with an overall reported prevalence of approximately 10%. infection.

25 Apr 2007

Babies are exposed to perfluorooctane sulfonate and perfluorooctanoate in the womb

An analysis of nearly 300 umbilical cord blood samples led by researchers at the Johns Hopkins Bloomberg School of Public Health shows that newborn babies are exposed to perfluorooctane sulfonate (PFOS) and perfluorooctanoate (PFOA) while in the womb.

25 Apr 2007

High workloads for pharmacists increase the potential for medication errors

The risk of dispensing potentially harmful combinations of medications that could result in a drug interaction increased by 3 percent for each additional prescription filled per hour.

25 Apr 2007

Performance league tables are linked to lower death rates after major heart surgery

The findings are based on almost 26,000 patients who had coronary artery bypass surgery (CABG) for the first time between1997 to 2005, in the north west of England.

25 Apr 2007

PDL BioPharma's European patent claims upheld

PDL BioPharma has announced that the Opposition Division of the European Patent Office decided at an oral proceeding to uphold claims in the company's European Patent No. 0 451 216 ('216 patent) that are virtually identical to the claims remitted to the Opposition Division by the Board of Appeal.

25 Apr 2007

Valid consent for genomic epidemiology in developing countries

Genetic research has the potential to improve global health by discovering what makes people susceptible or resistant to certain diseases, and what causes the diseases themselves, thereby guiding prevention efforts.

25 Apr 2007

Inner city kids from poor families much more likely to seek emergency care for asthma

Inner city children from poor families are much more likely to seek emergency care for asthma than their more affluent peers, finds research published ahead of print in Thorax.

25 Apr 2007

NHS together now?

Health minister Andy Burnham got a mixed reception when he spoke to UNISON's health conference in Brighton.

25 Apr 2007

Lisinopril could help stroke victims

A University of Leicester study could help to provide a new lease of life for patients who have suffered a stroke.

25 Apr 2007

Surprising new theory on antibiotic resistance

A surprising new theory developed at the University of Nebraska Medical Center (UNMC) in Omaha, Nebraska, suggests that some bacterial cells act as "suicide bombers" in cell communities, with the altruistic intention of dying for the common good - and in the process, strengthening other cells that then become resistant to antibiotic drugs.

25 Apr 2007

New data supports safety of ranolazine but not its effectiveness

The anti-anginal medication ranolazine was shown to be safe in regard to certain outcomes but did not reduce the risk of major cardiovascular events such as death, heart attack or recurrent ischemia following acute coronary syndromes, according to a study in the April 25 issue of JAMA .

25 Apr 2007

Neuromed licenses chronic pain product from ALZA Corporation

Neuromed Pharmaceuticals has announced that it has licensed from ALZA Corporation the exclusive U.S. rights to develop and commercialize OROS(R) Hydromorphone, an extended release formulation of a potent opioid analgesic in Phase 3 clinical development.

25 Apr 2007

New biotech company develops UD-patented technologies for repairing genes

OrphageniX Inc., a new biotechnology company founded by University of Delaware researchers, has been established in Wilmington to develop and commercialize UD-patented technologies for repairing genes that cause rare, hereditary diseases such as sickle cell anemia and spinal muscular atrophy.

25 Apr 2007

1.2 million hospitalized patients experienced an adverse drug event

In 2004, 1.2 million hospitalized patients experienced an adverse drug event, 90 percent of which were due to a side effect from a medication that was properly administered, according to the latest News and Numbers from the Agency for Healthcare Research and Quality.

25 Apr 2007

Moonlighting enzyme linked to Friedreich's ataxia

Friedreich's ataxia is one of those diseases few have heard of unless you know someone with the condition.

25 Apr 2007

Luminex Corporation licenses cystic fibrosis gene patent from John Hopkins

Luminex Corporation has announced that it has acquired a non-exclusive license from The Johns Hopkins University for the rights to use the university's patented cystic fibrosis genetic markers in the company's molecular diagnostic products sold in the United States.

From Luminex 25 Apr 2007

Pregnant U.S. women commonly smoke

While pregnancy may be considered an effective motivator for smoking cessation, results of a new study by researchers at the Mailman School of Public Health indicate that pregnant U.S. women commonly smoke, placing themselves and their unborn children at risk for health and developmental complications.

25 Apr 2007

Succimer therapy improves balance and movement in lead-exposed children

University of Cincinnati (UC) environmental health researchers say a therapy commonly used to remove dangerously high levels of lead from the body may also improve muscle functions associated with postural balance and movement in lead-exposed children.

25 Apr 2007